| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $216.9M | $274.8M | $297.9M |
| YoY Revenue Growth % | -21.1% | -7.7% | — |
| Gross Profit | $162.1M | $193.7M | — |
| Gross Margin % | 74.8% | 70.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $4.4M | -$102.3M | -$163.9M |
| Operating Margin % | 2.0% | -37.2% | -55.0% |
| Net Income (GAAP) | $40.4M | $112.7M | $179.9M |
| EBITDA (Normalized) | $5.5M | -$101.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $25.8M | $24.2M | $49.9M |
| Capital Expenditures (CapEx) | $1.4M | $882.0K | — |
| Free Cash Flow (FCF) | $24.4M | $23.4M | $49.9M |
| FCF Margin % | 11.3% | 8.5% | 16.8% |
| Return on Invested Capital (ROIC %) | 2.4% | -38.1% | — |
| Cash & Short-Term Equivalents | $29.4M | $56.4M | — |
| Total Debt (Short + Long Term) | $224.7M | $287.0M | — |
| Total Stockholders' Equity | -$48.4M | -$18.3M | — |